Oruka Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 08/13/2026 | 9.06 M | $862.02 M | 21.88% | 14.41% |
| BLACKROCK, INC. | 08/07/2026 | 4.99 M | $474.92 M | 41.48% | 7.94% |
| VR ADVISER, LLC | 08/14/2026 | 4.15 M | $394.81 M | 0.00% | 6.60% |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 08/14/2026 | 3.71 M | $352.63 M | 0.00% | 5.89% |
| CAPITAL WORLD INVESTORS | 08/12/2026 | 3.40 M | $323.73 M | 100.00% | 5.41% |
| RTW INVESTMENTS, LP | 08/14/2026 | 3.14 M | $298.74 M | 52.52% | 4.99% |
| STATE STREET CORP | 08/07/2026 | 2.67 M | $254.38 M | 65.67% | 4.25% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 2.36 M | $224.69 M | 26.96% | 3.76% |
| PARADIGM BIOCAPITAL ADVISORS LP | 08/14/2026 | 2.14 M | $204.09 M | -7.58% | 3.41% |
| DEEP TRACK CAPITAL, LP | 08/14/2026 | 1.93 M | $183.30 M | -5.32% | 3.06% |
| BELLEVUE GROUP AG | 08/14/2026 | 1.66 M | $157.71 M | 226.86% | 2.64% |
| FRANKLIN RESOURCES INC | 08/13/2026 | 1.62 M | $154.31 M | 61.49% | 2.58% |
| REMEDIUM CAPITAL PARTNERS, LLC | 08/07/2026 | 1.57 M | $149.00 M | 0.00% | 2.49% |
| RA CAPITAL MANAGEMENT, L.P. | 08/14/2026 | 1.55 M | $147.95 M | 100.00% | 2.47% |
| VIKING GLOBAL INVESTORS LP | 08/14/2026 | 1.50 M | $143.09 M | -43.62% | 2.39% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 1.43 M | $136.11 M | 49.75% | 2.27% |
| JUPITER TOPCO LLC | 08/14/2026 | 1.38 M | $130.97 M | 100.00% | 2.19% |
| PERCEPTIVE ADVISORS LLC | 08/14/2026 | 1.35 M | $128.01 M | -3.61% | 2.14% |
| POLAR CAPITAL HOLDINGS PLC | 08/14/2026 | 1.23 M | $116.93 M | 17.27% | 1.95% |
| CITADEL ADVISORS LLC | 09/02/2026 | 1.12 M | $106.50 M | 11.06% | 1.78% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 08/14/2026 | 1.10 M | $105.04 M | 100.00% | 1.76% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 1.08 M | $102.69 M | 9,773.86% | 1.72% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2026 | 838.60 K | $79.81 M | 15.28% | 1.33% |
| AVIDITY PARTNERS MANAGEMENT LP | 08/14/2026 | 760.42 K | $72.37 M | 0.00% | 1.21% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 08/14/2026 | 658.30 K | $62.65 M | 100.00% | 1.05% |
| JPMORGAN CHASE & CO | 08/12/2026 | 655.03 K | $60.74 M | 2,795.79% | 1.04% |
| ABRDN PLC | 07/31/2026 | 646.94 K | $61.57 M | 754.84% | 1.03% |
| UBS GROUP AG | 08/13/2026 | 639.36 K | $60.85 M | 201.20% | 1.02% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 08/12/2026 | 631.43 K | $60.09 M | 101.65% | 1.00% |
| PICTET ASSET MANAGEMENT HOLDING SA | 07/30/2026 | 619.08 K | $58.91 M | 100.00% | 0.98% |
| AFFINITY ASSET ADVISORS, LLC | 08/13/2026 | 590.00 K | $56.15 M | 18.08% | 0.94% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 582.41 K | $55.43 M | 65.98% | 0.93% |
| CORMORANT ASSET MANAGEMENT, LP | 08/14/2026 | 533.34 K | $50.76 M | 0.00% | 0.85% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 433.41 K | $41.25 M | 34.62% | 0.69% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 433.41 K | $41.25 M | 100.00% | 0.69% |
| NORTHERN TRUST CORP | 08/13/2026 | 428.89 K | $40.82 M | 43.42% | 0.68% |
| VOYA INVESTMENT MANAGEMENT LLC | 08/12/2026 | 401.15 K | $38.18 M | 502.33% | 0.64% |
| LORD, ABBETT & CO. LLC | 08/14/2026 | 390.06 K | $37.12 M | 100.00% | 0.62% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 365.63 K | $34.80 M | 42.23% | 0.58% |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 08/03/2026 | 364.10 K | $34.65 M | 100.00% | 0.58% |
| SYNERGY ASSET MANAGEMENT, LLC | 07/22/2026 | 356.30 K | $33.91 M | -25.18% | 0.57% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2026 | 355.00 K | $33.79 M | 86.81% | 0.56% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 352.82 K | $33.58 M | 252.50% | 0.56% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 08/13/2026 | 352.80 K | $33.58 M | 133.79% | 0.56% |
| CANDRIAM S.C.A. | 08/13/2026 | 352.72 K | $33.54 M | -14.18% | 0.56% |
| HOLOCENE ADVISORS, LP | 08/14/2026 | 305.95 K | $29.12 M | 64.92% | 0.49% |
| JENNISON ASSOCIATES LLC | 08/03/2026 | 299.26 K | $28.48 M | 69.38% | 0.48% |
| WOODLINE PARTNERS LP | 08/14/2026 | 285.25 K | $27.15 M | -50.38% | 0.45% |
| BRAIDWELL LP | 08/14/2026 | 278.16 K | $26.47 M | 100.00% | 0.44% |
| SIREN, L.L.C. | 08/13/2026 | 250.00 K | $23.79 M | 100.00% | 0.40% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Oruka Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 291 institutional investors and hedge funds held shares of Oruka Therapeutics Inc.. The most heavily invested institutionals were:
FMR LLC: 9.06 M
BlackRock, Inc.: 4.99 M
VR Adviser, LLC: 4.15 M
Fairmount Funds Management LLC: 3.71 M
Capital World Investors: 3.4 M
RTW INVESTMENTS, LP: 3.14 M
118.61% of Oruka Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 77.11 M shares in the last 24 months. This purchase volume represents approximately $2.59 B in transactions.